The Utrecht Centre for Affordable Biotherapeutics (“UCAB”) is a collaboration between Utrecht University and the World Health Organization. UCAB is a non-profit foundation that facilitates the development and sustainable production of high quality and affordable biotherapeutics for patients in low- and middle-income countries (LMICs)

Mission

The mission of UCAB is to improve global health by enabling the sustainable production of high quality and affordable biotherapeutics that are accessible to patients in low-and middle-income countries (LMICs). UCAB focusses on the development of biotherapeutics with the greatest impact on public health in LMICs, which are preferably included in the Essential Medicines List (EML) or the Neglected Tropical Disease (NTD) portfolio of the World Health Organization. 

News

20 December 2018
“Policies should ensure that medicines are optimally accessible, but sometimes have unwanted side effects”
1 December 2018
Using biotechnology and modern drug development approaches to develop novel snakebite antivenoms
1 November 2018
Building bridges to realise biological pharmaceutical therapies

Pages

RSS